We are Sorry, This Page doesn't Exist
Duterte Can Cut U.S. Defense Ties, But It Would Take Awhile: Q&A
In his more than three years as Philippine president, Rodrigo Duterte has made a habit of casting doubt on the future of his country’s longstanding defense ties with the U.S., usually in response to U.S. concerns about his deadly drug war. Now heâ.....»»
Market Extra: Trump’s State of the Union speech could dent health care stocks, but boost the broader market, analysts say
President Trump’s third State of the Union address could be of great interest to investors, as reports suggest he may propose new efforts to lower prescription drug prices, address trade policy and propose new tax cuts......»»
Borderlands: CFI Logistica Expands Mexico Operations; Drug Trafficker Who Used Trucks Convicted
Borderlands is a weekly rundown of developments in the world of United States-Mexico cross-border trucking and trade. This week: CFI Logistica expands cross-b.....»»
A $50 Billion Hole Emerges In Trump"s China Trade Deal
A $50 Billion Hole Emerges In Trump's China Trade Deal Now that the dust has settled on the US-China trade deal and analysts have had some time to pore over its 90+ pages, various chapters and (non-bind.....»»
Factbox: How China tariffs on U.S. commodities, energy stand after Phase 1 trade deal
China and the United States have agreed to terms of a Phase 1 trade deal on Jan 15 but Beijing has not reduced or waived tariffs on any commodities or energy further......»»
Stephen Moore: Drug companies are demonized by Washington but does the public think about the trade-offs?
The public is roughly twice as likely to survive a cancer diagnosis or a heart attack today compared with four decades ago......»»
Microcap Correvio Pharma stock slammed after FDA rejects anti-arrhythmic drug
Shares of microcap Correvio Pharma Corp. slid about 12% in premarket trade Tuesday, after the company said it has received a Complete Response Letter from the U.S. Food and Drug Ad.....»»
Factbox: How China tariffs on U.S. commodities, energy stand after "phase one" trade deal
China and the United States have agreed terms of a "phase one" trade deal under which Washington reduced some tariffs and Beijing canceled retaliatory duties that were previously scheduled to take effect on Dec. 15......»»
New North America trade deal hits snag as Mexico objects to U.S. labor inspectors
The problem emerges just days after the accord was signed......»»
The Wall Street Journal: Trump administration considers scaling back drug protections to break logjam over trade pact
The move is an effort to get Democratic support for a new trade pact with Mexico and Canada......»»
Stocks tick up on upbeat China factory reports, trade talk hopes
Global shares shuffled marginally higher on Monday to stand just short of the record peak struck in January 2018, with buyers encouraged by upbeat China manufacturing surveys and hopes that China and the United States will agree a preliminary trade deal......»»
Bristol-Myers stock slides premarket after melanoma trial fails to meet main goal
Bristol-Myers Squibb Co. shares slid 0.9% in premarket trade Wednesday, after the drug company said a trial of opdivo p.....»»
Bristol-Myers Squibb wins antitrust approval to buy Celgene, but must divest psoriasis drug
Bristol-Myers Squibb Co and Celgene Corp have won U.S. antitrust approval for their merger on condition that they sell Celgene's psoriasis drug Otezla, the Federal Trade Commission said in a statement on Friday......»»
Trade deal doubts clip world stock rally, oil wavers
Oil prices faltered and global equity markets slid on Friday, halting a week-long record-setting rally on hopes a U.S.-China trade deal was near, as investors parsed statements from Beijing and Washington on where they stand on rolling back tariffs......»»
Trade deal doubts clip world stock rally, oil falls
Oil prices fell and global equity markets slid on Friday, halting a week-long rally on hopes an end to the U.S.-China trade war was near, as investors parsed statements from Beijing and Washington on where they stand on rolling back tariffs......»»
Cancer Care: Clinical trials in Triad accelerate innovative treatments
As cancer care evolves with each new drug, treatment or therapy that emerges through important research, so too evolve the methods by which these discoveries are made......»»
U.S. lobbying for U.K. drug price rise prompts Johnson, Corbyn clash over post-Brexit trade pact
A television report saying U.S. companies are lobbying the British government over drug prices was a topic of debate in Britain’s Parliament on Wednesday in what is expected to be a hot topic in the run-up to December’s U.K. general election......»»
Pfizer shares jump premarket as earnings beat estimates and company raises guidance
Pfizer Inc. shares rose 3.3% in premarket trade Tuesday, after the drug company beat ea.....»»
FDA, FTC Warn CBD Retailer Rooted Apothecary On Health Claims, Unapproved Products
The Food and Drug Administration and Federal Trade Commission issued a joint warning letter Tuesday a joint warning letter to read more.....»»
AstraZeneca Shares Trade Higher After FDA Grants Breast Cancer Drug Priority Review
AstraZeneca plc (NYSE: AZN) and partner DAIICHI SANKYO/S ADR (OTC: DSNKY) announced positive news Thursday on their HER-2 targeting antibody drug conjugate, or ADC. read more.....»»